Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia.
Kim HT, Shaughnessy CJ, Rai SC, Reynolds C, Ho VT, Cutler C, Koreth J, Gooptu M, Romee R, Nikiforow S, Armand P, Alyea EP, Antin JH, Wu CJ, Soiffer RJ, Ritz J, Brown JR.
Kim HT, et al.
Blood Adv. 2020 Sep 8;4(17):4113-4123. doi: 10.1182/bloodadvances.2020002184.
Blood Adv. 2020.
PMID: 32882002
Free PMC article.